drugset / Trial / NCT06063538

Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone

NCT06063538

Phase 0 Recruiting 63 enrolled University of Chicago Helios Cardio Inc. · collab
RandomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.

Timeline

Start
2024-02-15
Primary completion
2027-06
Completion
2027-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 600 mg Other

Indications